Form EFFECT Scribe Therapeutics,

July 24, 2026 6:04 AM EDT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 23, 2026 4:00 P.M.
Form: S-1
CIK: 0001853921
Company Name: Scribe Therapeutics, Inc.
File Number: 333-297246


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings